Senna and the formation of aberrant crypt foci and tumors in rats treated with azoxymethane

F Borrelli, R Capasso, G Aviello, G Di Carlo, A A Izzo, N Mascolo, F Capasso

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Chronic use of anthraquinone laxatives has been blamed for the induction of habituation and the development of colonic cancer, but there are no definitive studies which have demonstrated this. To evaluate the carcinogenic potential of anthraquinones, the effect of long-term senna pod extract (SE) treatment on either healthy rats or rats treated with an initiating tumor agent (azoxymethane--AOM) has been studied. SE (30 and 60mg/kg), administered for 110 weeks, did not induce the development of aberrant crypt foci (ACF) and tumors in healthy rats. The development of ACF and tumors in rats treated with AOM were significantly reduced by SE (30 and 60 mg/kg). These results suggest that a chronic SE use does not predispose to colon cancer. By contrast, SE might exert an anti-tumoral activity on rat colon carcinogenesis.

Original languageEnglish
Pages (from-to)501-5; discussion 505
Number of pages5
JournalPhytomedicine
Volume12
Issue number6-7
Publication statusPublished - Jun 2005

Fingerprint

Senna Extract
Aberrant Crypt Foci
Azoxymethane
Anthraquinones
Neoplasms
Colonic Neoplasms
Laxatives
Colon
Carcinogenesis

Keywords

  • Adenocarcinoma
  • Animals
  • Anticarcinogenic Agents
  • Azoxymethane
  • Cathartics
  • Colonic Neoplasms
  • Male
  • Phytotherapy
  • Precancerous Conditions
  • Rats
  • Rats, Wistar
  • Senna Extract
  • Senna Plant
  • Journal Article
  • Research Support, Non-U.S. Gov't

Cite this

Borrelli, F., Capasso, R., Aviello, G., Di Carlo, G., Izzo, A. A., Mascolo, N., & Capasso, F. (2005). Senna and the formation of aberrant crypt foci and tumors in rats treated with azoxymethane. Phytomedicine, 12(6-7), 501-5; discussion 505.

Senna and the formation of aberrant crypt foci and tumors in rats treated with azoxymethane. / Borrelli, F; Capasso, R; Aviello, G; Di Carlo, G; Izzo, A A; Mascolo, N; Capasso, F.

In: Phytomedicine, Vol. 12, No. 6-7, 06.2005, p. 501-5; discussion 505.

Research output: Contribution to journalArticle

Borrelli, F, Capasso, R, Aviello, G, Di Carlo, G, Izzo, AA, Mascolo, N & Capasso, F 2005, 'Senna and the formation of aberrant crypt foci and tumors in rats treated with azoxymethane', Phytomedicine, vol. 12, no. 6-7, pp. 501-5; discussion 505.
Borrelli F, Capasso R, Aviello G, Di Carlo G, Izzo AA, Mascolo N et al. Senna and the formation of aberrant crypt foci and tumors in rats treated with azoxymethane. Phytomedicine. 2005 Jun;12(6-7):501-5; discussion 505.
Borrelli, F ; Capasso, R ; Aviello, G ; Di Carlo, G ; Izzo, A A ; Mascolo, N ; Capasso, F. / Senna and the formation of aberrant crypt foci and tumors in rats treated with azoxymethane. In: Phytomedicine. 2005 ; Vol. 12, No. 6-7. pp. 501-5; discussion 505.
@article{33fe032519b743219850945cf608eb5c,
title = "Senna and the formation of aberrant crypt foci and tumors in rats treated with azoxymethane",
abstract = "Chronic use of anthraquinone laxatives has been blamed for the induction of habituation and the development of colonic cancer, but there are no definitive studies which have demonstrated this. To evaluate the carcinogenic potential of anthraquinones, the effect of long-term senna pod extract (SE) treatment on either healthy rats or rats treated with an initiating tumor agent (azoxymethane--AOM) has been studied. SE (30 and 60mg/kg), administered for 110 weeks, did not induce the development of aberrant crypt foci (ACF) and tumors in healthy rats. The development of ACF and tumors in rats treated with AOM were significantly reduced by SE (30 and 60 mg/kg). These results suggest that a chronic SE use does not predispose to colon cancer. By contrast, SE might exert an anti-tumoral activity on rat colon carcinogenesis.",
keywords = "Adenocarcinoma, Animals, Anticarcinogenic Agents, Azoxymethane, Cathartics, Colonic Neoplasms, Male, Phytotherapy, Precancerous Conditions, Rats, Rats, Wistar, Senna Extract, Senna Plant, Journal Article, Research Support, Non-U.S. Gov't",
author = "F Borrelli and R Capasso and G Aviello and {Di Carlo}, G and Izzo, {A A} and N Mascolo and F Capasso",
year = "2005",
month = "6",
language = "English",
volume = "12",
pages = "501--5; discussion 505",
journal = "Phytomedicine",
issn = "0944-7113",
publisher = "ELSEVIER GMBH, URBAN & FISCHER VERLAG",
number = "6-7",

}

TY - JOUR

T1 - Senna and the formation of aberrant crypt foci and tumors in rats treated with azoxymethane

AU - Borrelli, F

AU - Capasso, R

AU - Aviello, G

AU - Di Carlo, G

AU - Izzo, A A

AU - Mascolo, N

AU - Capasso, F

PY - 2005/6

Y1 - 2005/6

N2 - Chronic use of anthraquinone laxatives has been blamed for the induction of habituation and the development of colonic cancer, but there are no definitive studies which have demonstrated this. To evaluate the carcinogenic potential of anthraquinones, the effect of long-term senna pod extract (SE) treatment on either healthy rats or rats treated with an initiating tumor agent (azoxymethane--AOM) has been studied. SE (30 and 60mg/kg), administered for 110 weeks, did not induce the development of aberrant crypt foci (ACF) and tumors in healthy rats. The development of ACF and tumors in rats treated with AOM were significantly reduced by SE (30 and 60 mg/kg). These results suggest that a chronic SE use does not predispose to colon cancer. By contrast, SE might exert an anti-tumoral activity on rat colon carcinogenesis.

AB - Chronic use of anthraquinone laxatives has been blamed for the induction of habituation and the development of colonic cancer, but there are no definitive studies which have demonstrated this. To evaluate the carcinogenic potential of anthraquinones, the effect of long-term senna pod extract (SE) treatment on either healthy rats or rats treated with an initiating tumor agent (azoxymethane--AOM) has been studied. SE (30 and 60mg/kg), administered for 110 weeks, did not induce the development of aberrant crypt foci (ACF) and tumors in healthy rats. The development of ACF and tumors in rats treated with AOM were significantly reduced by SE (30 and 60 mg/kg). These results suggest that a chronic SE use does not predispose to colon cancer. By contrast, SE might exert an anti-tumoral activity on rat colon carcinogenesis.

KW - Adenocarcinoma

KW - Animals

KW - Anticarcinogenic Agents

KW - Azoxymethane

KW - Cathartics

KW - Colonic Neoplasms

KW - Male

KW - Phytotherapy

KW - Precancerous Conditions

KW - Rats

KW - Rats, Wistar

KW - Senna Extract

KW - Senna Plant

KW - Journal Article

KW - Research Support, Non-U.S. Gov't

M3 - Article

C2 - 16008128

VL - 12

SP - 501-5; discussion 505

JO - Phytomedicine

JF - Phytomedicine

SN - 0944-7113

IS - 6-7

ER -